Article Versions Notes

Ohkuma R, Ieguchi K, Watanabe M, Takayanagi D, Goshima T, Onoue R, Hamada K, Kubota Y, Horiike A, Ishiguro T, et al. Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies. Biomedicines. 2021; 9(12):1929. https://doi.org/10.3390/biomedicines9121929

Ohkuma, Ryotaro, Katsuaki Ieguchi, Makoto Watanabe, Daisuke Takayanagi, Tsubasa Goshima, Rie Onoue, Kazuyuki Hamada, Yutaro Kubota, Atsushi Horiike, Tomoyuki Ishiguro, and et al. 2021. "Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies" Biomedicines 9, no. 12: 1929. https://doi.org/10.3390/biomedicines9121929

Ohkuma, R., Ieguchi, K., Watanabe, M., Takayanagi, D., Goshima, T., Onoue, R., Hamada, K., Kubota, Y., Horiike, A., Ishiguro, T., Hirasawa, Y., Ariizumi, H., Tsurutani, J., Yoshimura, K., Tsuji, M., Kiuchi, Y., Kobayashi, S., Tsunoda, T., & Wada, S. (2021). Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies. Biomedicines, 9(12), 1929. https://doi.org/10.3390/biomedicines9121929